Articles of Science

News »

Interferon in Cuba, a prophecy come true

heberon

When Comandante en Jefe Fidel Castro inaugurated the Center for Genetic Engineering and Biotechnology (CIGB) on July 1, 1986, he said he expected more from combinations of alpha and gamma interferons than from the individual use of the products, first produced in Cuba 39 years ago, on May 28, 1981. That prediction became a reality on August 4, 2016, when Heberferon, a new formulation of IFNS alpha and gamma interferons for the treatment of basal cell carcinoma.

News »

Fidel versus COVID-19 and beyond

Fidel covid

The fact that Cuba’s response to the COVID-19 has been far more effective than most countries in the region, including the United States and also several European nations, is a reality that is becoming evident. A health system based on prevention, with a presence in all communities of medical offices, organized by neighborhood and linked to polyclinics, as well as general and specialized hospitals.

News »

Itolizumab monoclonal antibody in the COVID-19 battle

interferon cuba

In 2014 the novel medication won a National Award from the Cuban Academy of Sciences (ACC) in the Biomedical Sciences arena, and since April, this year, the humanized monoclonal antibody, Itolizumab, has been included in the country’s COVID-19 treatment protocol. To learn first-hand about the characteristics and indications of this drug, created at the Center for Molecular Immunology (CIM), and winner of the World Intellectual Property Organization (WIPO) Gold Medal in 2015.

News »

Another COVID-19 medication under development in Cuba

Med sol laboratorios

MedSol Laboratories is working to develop the antiretroviral medication Kaletra, a drug that has shown its effectiveness worldwide in combating COVID-19. According to Adalberto Izquierdo Castro, head of Research and Development at MedSol’s production unit (UEB) Novatec, the drug is in the development stage, with three pilot batches produced and physical-chemical analyses conducted. Izquierdo told ACN that the next step would be to compare the Cuban product with the lead product.

News »

There should be no barriers to scientific cooperation between Cuba and the United States

Congreso Cardiologisy

The blockade of Cuba is anachronistic and must cease, said Dr. Matthew W. Martinez, a renowned U.S. cardiologist participating in the International Cardiology Congress, Cardiovilla 2019, which took place in Cayo Santa María, who added that no there should be no barriers to collaboration between Cuban scientists and those of the United States.

News »

Invasive plant species in Cuba take their toll

Cuba bosques

A total of 323 plants had been identified as invasive alien species in Cuba, which have the potential to impact biological diversity and affect agricultural production. Boasting an estimated 7,000 to 7,500 plant species, of which some 53% are exclusive to the archipelago, Cuba is one of the islands with the greatest diversity of plants and endemism in the Caribbean and the world.

News »

Produce more, and better

produce

The importance of applying science and technology in national industry investments, to allow for progress toward a sustainable, prosperous society, was reaffirmed during President Díaz-Canel’s policy implementation review meetings.

News »

Is Diabetes actually the eighth cause of death in Cuba?

Diabetes

Although the data from the 2018 Statistical Yearbook of Health, place diabetes as the eighth cause of death in Cuba, specialists insist on not losing sight of the fact that this condition constitutes an important risk factor for the diseases currently topping the list.

News »

The Pablo Center in Havana’s 2019 Design Biennial

memoria libro

Graphic design and the poster are natural components of the work done by the Pablo de la Torriente Brau Cultural Center, and two exhibitions presented in the 2019 Havana Design Biennial accentuate this reality.

News »

Cuban healthcare travels any distance

medico cubano

“And where are you from?” That was the inevitable greeting in the presence of a young woman, small in statute, but undertaking work of a huge dimension. Her name: Edenys Reyes Galán. She was 27 years old and I met her at the doors of the Los Manacales Popular Medical Office (CMP), in Casacoima, one of the municipalities of Venezuela’s easternmost state, Delta Amacuro.